site stats

Bivalirudin hepatic or renal clearance

WebTraductions en contexte de "fonction hépatique ou rénale est altérée" en français-anglais avec Reverso Context : si votre fonction hépatique ou rénale est altérée WebIts clearance exceeded hepatic or renal blood flow suggesting metabolic clearance. At 24 h after i.v. administration of [3H] ... Bivalirudin is cleared partly by a renal mechanism (glomerular filtration) and, there-fore, its dose needs to be adjusted in patients with renal impairment (43,44). The half-life. CLINICAL APPLICATIONS ((Acute ...

GI Tables For Anticoagulation Discontinuation 2024, …

WebMar 1, 2024 · The disposition of bivalirudin was studied in PTCA patients with mild, moderate and severe renal impairment. The clearance of bivalirudin was reduced approximately 21% in patients with moderate and severe renal impairment and was reduced approximately 70% in dialysis-dependent patients [see Clinical Pharmacology ]. WebTherefore, severe renal impairment and hepatic impairment both cause a reduction in its rate of clearance [81,82]. From: Meyler's Side Effects of Drugs (Sixteenth Edition), 2016. ... Patients with moderate and severe renal impairment have reductions in bivalirudin clearance. An analyses of data for 4312 patients with unstable angina showed ... greater glyph of igni https://crofootgroup.com

fonction hépatique ou rénale est altérée - Traduction en anglais ...

WebRenal impairment. Bolus Dose. No reduction required for any degree of renal impairment; IV infusion. Moderate (CrCl 30-59 mL/min): 1.75 mg/kg/hr; Severe (CrCl ; 30 mL/min): 1 … WebBivalirudin is cleared from plasma by a combination of renal mechanisms and proteolytic cleavage Half-life: -Normal renal function (≥ 90 mL/min) = 25 minutes -Mild renal … Webbivalirudin are widely used as anticoagulants in cardiovas-cular medicine, including for thrombosis prevention during coronary angiography (CAG) and percutaneous coronary … greater glyph of stamina eso

Effects of Bivalirudin and Unfractionated Heparin on Liver …

Category:Bivalirudin, Ecarin, Plasma - Saint Francis Healthcare System

Tags:Bivalirudin hepatic or renal clearance

Bivalirudin hepatic or renal clearance

DailyMed - BIVALIRUDIN RTU- bivalirudin injection, solution

WebSep 15, 2024 · The clearance of bivalirudin was reduced approximately 20% in patients with moderate and severe renal impairment and was reduced approximately 80% in … National Center for Biotechnology Information

Bivalirudin hepatic or renal clearance

Did you know?

WebFrequently, bivalirudin is used for prevention of treatment of thrombosis in patients with HIT with or without thrombosis and with renal and/or hepatic dysfunction. Bivalirudin is … WebParenteral direct thrombin inhibitors, which directly inhibit thrombin independent of antithrombin, include argatroban and bivalirudin. Table 1. Parenteral Anticoagulant …

WebJun 1, 2024 · Bivalirudin does not bind to plasma proteins (other than thrombin) or to red blood cells. Elimination. Bivalirudin has a half-life of 25 minutes in PTCA patients with normal renal function. The total body clearance of Bivalirudin in PTCA patients with normal renal function is 3.4 mL/min/kg. Metabolism. Bivalirudin is metabolized by … WebBivalirudin is a 20 amino-acids hirudin-analogue with a molecular mass of 2’180 Da and a half-life of ~25 minutes; it is eliminated by proteolysis and for ~20% by renal clearance . Both bind human thrombin reversibly, …

WebPopulation pharmacokinetics and pharmacodynamics of bivalirudin in young healthy Chinese volunteers

WebJul 1, 2002 · Bivalirudin is cleared from plasma by a combination of renal mechanisms and proteolytic cleavage, with a half-life of 25 min in patients with normal renal function [27]. The clearance of ...

WebInitial dosing Please use the following for the initial dose of bivalirudin in heparin-induced thrombocytopenia (HIT): *Based on a review of internal data as well as most recent … fling ushWebMay 23, 2024 · Bivalirudin does not bind to plasma proteins (other than thrombin) or to red blood cells. Elimination. Bivalirudin has a half-life of 25 minutes in PTCA patients with normal renal function. The total body … greater glyph of magicka esoWebOct 17, 2024 · Bivalirudin is a direct thrombin inhibitor that may require lower doses to reach therapeutic targets in patients receiving renal replacement therapy . While a small … greater glyph of magicka with taWebHalf-life 17 to 21 hours; prolonged in renal impairment, older adults, and low body weight; Possible reversal with andexanet alfa; Apixaban: Oral agent; Eliminated by the kidney and liver (less dependent on kidney function than other DOACs); no dose adjustment is needed for CrCl ≥25 mL/minute or mild to moderate hepatic impairment greater glory movieWebApr 9, 2024 · This study compared the effects of bivalirudin and UFH on liver/renal function in patients with coronary artery disease who underwent CAG, with or without PCI. ... Compared with UFH or glycoprotein IIb/IIIa inhibitors, the clearance of bivalirudin is less dependent on renal function,2 and bivalirudin is characterized by rapid onset and fewer ... greater glory of godWebApr 3, 2024 · Given its peptide structure, bivalirudin is partially metabolized by serum proteases. Additionally, ~20% of its clearance is due to renal excretion. Dose adjustment … greater gold coastWebJun 1, 2024 · Bivalirudin for Injection is indicated for use as an anticoagulant for use in patients undergoing percutaneous coronary intervention (PCI) including patients with heparin-induced … greater glory scripture